The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
Jiaojiao Huang,Xuemin Peng,Kun Dong,Jing Tao,Yan Yang
DOI: https://doi.org/10.2147/DMSO.S305054
2021-05-25
Abstract:Jiaojiao Huang, Xuemin Peng, Kun Dong, Jing Tao, Yan Yang Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China Correspondence: Yan Yang Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei, 430030, People's Republic of China Tel +86-27-83663331 Fax +86-27-83662883 Email Aim: This study aimed to compare HOMA-IR, leptin, and resistin as the risk factors for diabetic nephropathy in the type 2 diabetes mellitus (T2DM) patients with different BMI classifications. Materials and Methods: A total of 309 patients with T2DM were enrolled in this cross-sectional study. All participants were divided into three groups according to BMI: the normal weight group (18.5 kg/m 2 ≤BMI< 24 kg/m 2 ), the overweight group (24kg/m 2 ≤BMI< 28 kg/m 2 ) and the obesity group (BMI≥ 28 kg/m 2 ). The clinical information and laboratory examinations were recorded in detail. Leptin and resistin levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: Higher HOMA-IR, leptin and resistin levels were found to be the risk factors for diabetic nephropathy when we made comparisons in the total population ( P < 0.05). In the normal weight group, logistic regression analysis showed that T2DM patients with higher HOMA-IR (OR=4.210, P =0.001), leptin (OR=2.474, P =0.031) and resistin levels (OR=8.299, P < 0.001) had nearly 4-fold, 2-fold and 8-fold risk for diabetic nephropathy, respectively, after adjustments. The receiver operating characteristic (ROC) curves indicated that the area under the curves (AUCs) of HOMA-IR and resistin were 0.699 (95% CI 0.617– 0.772) and 0.790 (95% CI 0.715– 0.854), respectively, which were significantly larger than the AUC of 0.5 (all P < 0.001). However, no significant association was observed between HOMA-IR, leptin, and resistin and renal complications (all P > 0.05) in the overweight and obesity groups in both logistic regression and AUC analysis. Conclusion: Higher insulin resistance, leptin and resistin levels were observed as risk factors for diabetic nephropathy in T2DM patients with lower BMI. These were not obvious in the overweight and obese patients. Keywords: type 2 diabetes mellitus, insulin resistance, leptin, resistin, diabetic nephropathy Type 2 diabetes mellitus (T2DM) has become a major public health challenge in China, which is primarily attributed to the rapidly increasing prevalence of obesity. 1 , 2 However, the mean body mass index (BMI) of Chinese patients with T2DM is relatively lower (about 25 kg/m 2 ). 1 , 2 Some reports have suggested that the risk of developing cardiovascular events and microvascular complications was higher in the non-obese patients than in the obese individuals with T2DM. 3 , 4 Diabetic nephropathy is a serious diabetic complication, and is one of the main causes of adverse outcomes in patients with diabetes. Epidemiological investigations revealed that patients with diabetic kidney disease have exceeded chronic kidney disease due to glomerulonephritis in China. 5 Thus, early identification and intervention on related risk factors for diabetic nephropathy in T2DM patients with different BMIs, particularly non-obese patients, is of great clinical significance. Leptin is a hormone that plays an essential role in regulating body weight and energy balance. 6 It is primarily secreted by white adipose tissue. Leptin replacement therapy facilitated the reversal of morbid obesity in leptin-deficient mice. 7 Additionally, the fundamental action of leptin on glucose homeostasis is also of great importance. Streptozotocin-related diabetic mice showed a dramatic improvement in insulin sensitivity, and demonstrated normalized glycemic levels after leptin treatment. 8 , 9 The association between leptin and diabetic nephropathy has been broadly explored. Serum leptin levels were found to be a risk factor for renal function decline, 10 while some reports have shown that there was no difference in leptin levels of diabetic patients with or without nephropathy. 11 Given that obesity is a typical characteristic of T2DM, we suspected that obesity mediated the contradictory relation -Abstract Truncated-